1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Erratum: Indian Academy of Cytologists National Guidelines for Cytopathology Laboratories for Handling Suspected and Positive COVID-19 (SARS-CoV-2) Patient Samples

      Journal of Cytology

      Wolters Kluwer - Medknow

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the article titled “Indian Academy of Cytologists National Guidelines for Cytopathology Laboratories for Handling Suspected and Positive COVID-19 (SARS-CoV-2) Patient Samples”, published on pages 67-71, Issue 2, Volume 37 of Journal of Cytology[1], the list of authors and affiliations is incorrectly written as “Radhika Srinivasan, Parikshaa Gupta, Bharat Rekhi, Prabal Deb, Vijay S. Nijhawan, Dev Prasoon, Venkat Iyer, Sandeep Mathur, Nalini Gupta, Meherbano Kamal, Madhu Mati Goel, Indranil Chakrabarti, Madhusmita Jena, Ram Nawal Rao, Arvind Rajwanshi, Siddaraju Raju, Surendra Verma, RGW Pinto”, “Indian Academy of Cytologists, India”. The correct list of authors and their affiliations should read as “Radhika Srinivasan, Parikshaa Gupta, Bharat Rekhi, Prabal Deb, Vijay S. Nijhawan, Dev Prasoon, Venkat Iyer, Sandeep Mathur, Nalini Gupta, Meherbano Kamal, Madhu Mati Goel, Indranil Chakrabarti, Madhusmita Jena, Ram Nawal Rao, Arvind Rajwanshi, Siddaraju Raju, Surendra Verma, RGW Pinto, Ranjan Agrawal, Shailaja Shukla”, “Indian Academy of Cytologists, India”. The “How to cite this article” section should read correctly as Srinivasan R, Gupta P, Rekhi B, Deb P, Nijhawan VS, Prasoon D, Iyer V, Mathur S, Gupta N, Kamal M, Goel MM, Chakrabarti I, Jena M, Rao RN, Rajwanshi A, Raju S, Verma S, Pinto RG, Agrawal R, Shukla S. Indian academy of cytologists national guidelines for cytopathology laboratories for handling suspected and positive COVID-19 (SARS-CoV-2) patient samples. J Cytol 2020;37:67-71.

          Related collections

          Most cited references 1

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Indian Academy of Cytologists National Guidelines for Cytopathology Laboratories for Handling Suspected and Positive COVID-19 (SARS-CoV-2) Patient Samples

          COVID-19, caused by the SARS-CoV-2 virus, has been declared a pandemic by the World Health Organization. This scenario has impacted the way we practice cytopathology. Cytology laboratories receive fresh and potentially infectious biological samples including those from the respiratory tract, from COVID-19 positive or suspected patients. Hence, the Indian Academy of Cytologists thought it necessary and fit to bring forth appropriate guidelines starting from transportation, receipt, processing, and reporting of samples in the COVID-19 era. The guidelines are prepared with the aim of safeguarding and protecting the health care personnel including laboratory staff, trainees and cytopathologists by minimizing exposure to COVID-19 so that they remain safe, in order to able to provide a continuous service. We hope that these national guidelines will be implemented across all cytopathology laboratories effectively.
            Bookmark

            Author and article information

            Journal
            J Cytol
            J Cytol
            JCytol
            Journal of Cytology
            Wolters Kluwer - Medknow (India )
            0970-9371
            0974-5165
            Oct-Dec 2020
            10 November 2020
            10 November 2020
            : 37
            : 4
            : 216
            Article
            JCytol-37-216
            10.4103/0970-9371.300381
            7984521
            Copyright: © 2020 Journal of Cytology

            This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

            Categories
            Erratum

            Pathology

            Comments

            Comment on this article